CMS Targets Leadless Pacers For Medicare Coverage Analysis

The Medicare agency signaled that it plans to establish a national coverage policy for leadless pacemakers in a memo issued May 18. The memo comes about one month after FDA approved the first such product, Medtronic’s Micra transcatheter leadless single-chamber pacemaker.

More from Policy & Regulation

More from Medtech Insight